Tapewire

Nasdaq · USD

RGNX

REGENXBIO Inc.

Export transactions ↓
Tapewire entity
2211
SEC CIK
0001590877
Parsed reports
367

Last 12 months

Inside the activity.

2 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202602
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2018 Filed Jan 7, 2019 21:27 UTC
Christmas Patrick J.SVP, General Counsel
GrantCommon Stock 337 $35.66 $12,016.58
Disclosure

SEC source: 0001562180-19-000222 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,006

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of July 1, 2018 through December 31, 2018. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on December 31, 2018.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:27 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001562180-18-005060 · primarydocument.xml · derivative · entry 5

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,472

Underlying: Common Stock · 5,000 shares

Expires 2026-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:27 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 720 $48.97 $35,258.40
Disclosure

SEC source: 0001562180-18-005060 · primarydocument.xml · nonDerivative · entry 4

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,669

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $48.77 to $49.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:27 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 2,055 $47.85 $98,331.75
Disclosure

SEC source: 0001562180-18-005060 · primarydocument.xml · nonDerivative · entry 3

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,389

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $47.54 to $48.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:27 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 2,225 $46.79 $104,107.75
Disclosure

SEC source: 0001562180-18-005060 · primarydocument.xml · nonDerivative · entry 2

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,444

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $46.21 to $47.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 21:27 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionCommon Stock 5,000 $12.10 $60,500.00
Disclosure

SEC source: 0001562180-18-005060 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 21:20 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 4,408 $47.74 $210,437.92
Disclosure

SEC source: 0001562180-18-005050 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $47.44 to $48.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 21:20 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 2,988 $46.81 $139,868.28
Disclosure

SEC source: 0001562180-18-005050 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,408

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $46.44 to $47.435. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 21:20 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 7,604 $46.11 $350,620.44
Disclosure

SEC source: 0001562180-18-005050 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,396

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $45.43 to $46.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 16:32 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 1,700 $47.74 $81,158.00
Disclosure

SEC source: 0001562180-18-005051 · primarydocument.xml · nonDerivative · entry 3

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,283

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $47.38 to $48.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 16:32 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 1,700 $46.47 $78,999.00
Disclosure

SEC source: 0001562180-18-005051 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,983

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $46.21 to $47.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 16:32 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 4,100 $45.73 $187,493.00
Disclosure

SEC source: 0001562180-18-005051 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,683

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $45.21 to $46.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 21:19 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 1,300 $61.33 $79,729.00
Disclosure

SEC source: 0001562180-18-004849 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $61.10 to $61.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 21:19 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 18,700 $60.34 $1,128,358.00
Disclosure

SEC source: 0001562180-18-004849 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,300

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 16:22 UTC
Yoo StephenChief Medical Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 20,414 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-18-004850 · primarydocument.xml · derivative · entry 5

Yoo Stephen · CIK 0001652825 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,830

Underlying: Common Stock · 20,414 shares

Expires 2024-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 247,900 shares, became exercisable as follows: 165,200 of the shares subject to the option are initial shares ("Initial Shares") and 82,700 of the shares subject to the option are contingent shares ("Contingent Shares"). 23,600 of the Initial Shares vested on October 13, 2014, 35,400 of the Initial Shares vested on October 13, 2015 and an additional 2,950 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 15% of the Contingent Shares were deemed vested as of October 13, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following October 13, 2014, with 25% of the remaining 85% of Contingent Shares having vested on October 13, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 16:22 UTC
Yoo StephenChief Medical Officer
SaleCommon Stock 507 $61.20 $31,028.40
Disclosure

SEC source: 0001562180-18-004850 · primarydocument.xml · nonDerivative · entry 4

Yoo Stephen · CIK 0001652825 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $61.15 to $61.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 16:22 UTC
Yoo StephenChief Medical Officer
SaleCommon Stock 13,053 $60.35 $787,748.55
Disclosure

SEC source: 0001562180-18-004850 · primarydocument.xml · nonDerivative · entry 3

Yoo Stephen · CIK 0001652825 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 507

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 16:22 UTC
Yoo StephenChief Medical Officer
SaleCommon Stock 6,854 $59.62 $408,635.48
Disclosure

SEC source: 0001562180-18-004850 · primarydocument.xml · nonDerivative · entry 2

Yoo Stephen · CIK 0001652825 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,560

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $59.00 to $59.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2018 Filed Dec 6, 2018 16:22 UTC
Yoo StephenChief Medical Officer
Exercise / conversionCommon Stock 20,414 $0.85 $17,351.90
Disclosure

SEC source: 0001562180-18-004850 · primarydocument.xml · nonDerivative · entry 1

Yoo Stephen · CIK 0001652825 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 30, 2018 Filed Dec 4, 2018 16:19 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $20.35 $0.00
Disclosure

SEC source: 0001562180-18-004807 · primarydocument.xml · derivative · entry 2

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,500

Underlying: Common Stock · 1,500 shares

Expires 2027-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 100,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on March 27, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
November 30, 2018 Filed Dec 4, 2018 16:19 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionCommon Stock 1,500 $20.35 $30,525.00
Disclosure

SEC source: 0001562180-18-004807 · primarydocument.xml · nonDerivative · entry 1

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2018 Filed Dec 3, 2018 21:19 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,784 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-18-004775 · primarydocument.xml · derivative · entry 3

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,000

Underlying: Common Stock · 12,784 shares

Expires 2025-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.

Read SEC document
November 29, 2018 Filed Dec 3, 2018 21:19 UTC SaleCommon Stock 12,784 $65.00 $830,960.00
Disclosure

SEC source: 0001562180-18-004775 · primarydocument.xml · nonDerivative · entry 2

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 29, 2018 Filed Dec 3, 2018 21:19 UTC Exercise / conversionCommon Stock 12,784 $3.76 $48,067.84
Disclosure

SEC source: 0001562180-18-004775 · primarydocument.xml · nonDerivative · entry 1

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 716 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 14

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,784

Underlying: Common Stock · 716 shares

Expires 2025-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F7 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,250 $0.00 Strike: $12.74 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 13

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2026-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,250 $0.00 Strike: $18.85 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 12

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2027-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following May 24, 2017.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,687 $0.00 Strike: $22.00 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 11

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,687 shares

Expires 2025-09-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 9,375 shares, became exercisable as follows: the option vested in nine equal monthly installments following September 16, 2015.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 883 $0.00 Strike: $49.45 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 10

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,292

Underlying: Common Stock · 883 shares

Expires 2028-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC SaleCommon Stock 18,786 $65.03 $1,221,653.58
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 8

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $65.00 to $65.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 716 $3.76 $2,692.16
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 7

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 6,250 $12.74 $79,625.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 6

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 6,250 $18.85 $117,812.50
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 5

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 4,687 $22.00 $103,114.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 4

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 27, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 883 $49.45 $43,664.35
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 3

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:18 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 8,620 $64.64 $557,196.80
Disclosure

SEC source: 0001562180-18-004726 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $64.18 to $64.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:18 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 11,380 $63.81 $726,157.80
Disclosure

SEC source: 0001562180-18-004726 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,620

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $63.17 to $64.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,721 $0.00 Strike: $49.45 $0.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · derivative · entry 9

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,175

Underlying: Common Stock · 1,721 shares

Expires 2028-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:20 UTC SaleCommon Stock 1,721 $65.00 $111,865.00
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 2

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 26, 2018 Filed Nov 28, 2018 21:20 UTC Exercise / conversionCommon Stock 1,721 $49.45 $85,103.45
Disclosure

SEC source: 0001562180-18-004727 · primarydocument.xml · nonDerivative · entry 1

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 21, 2018 Filed Nov 26, 2018 21:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 6,898 $61.92 $427,124.16
Disclosure

SEC source: 0001562180-18-004678 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $61.64 to $62.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 21, 2018 Filed Nov 26, 2018 21:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 6,802 $61.22 $416,418.44
Disclosure

SEC source: 0001562180-18-004678 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,898

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $60.64 to $61.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 21, 2018 Filed Nov 26, 2018 21:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 1,300 $60.09 $78,117.00
Disclosure

SEC source: 0001562180-18-004678 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,700

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $59.50 to $60.415. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 13,500 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 16

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,500

Underlying: Common Stock · 13,500 shares

Expires 2025-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F10 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,988 $0.00 Strike: $12.74 $0.00
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 15

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 2,988 shares

Expires 2026-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F8 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,688 $0.00 Strike: $22.00 $0.00
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 14

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,687

Underlying: Common Stock · 4,688 shares

Expires 2025-09-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F9 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 9,375 shares, became exercisable as follows: the option vested in nine equal monthly installments following September 16, 2015.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC SaleCommon Stock 21,176 $60.38 $1,278,606.88
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 10

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionCommon Stock 13,500 $3.76 $50,760.00
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 9

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionCommon Stock 2,988 $12.74 $38,067.12
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 8

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:26 UTC Exercise / conversionCommon Stock 4,688 $22.00 $103,136.00
Disclosure

SEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 7

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.